UnitedHealth Group Incorporated
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of UnitedHealth Group Incorporated generated cash of $29,068,000,000, which is more than the previous year. Cash used in financing activities reached the amount of -$11,529,000,000 last year. Net change in cash is therefore $2,062,000,000.
Cash Flow
| 2014 | 8.05B | -2.53B | -5.29B |
|---|---|---|---|
| 2015 | 9.74B | -18.39B | 12.23B |
| 2016 | 9.79B | -9.35B | -1.01B |
| 2017 | 13.59B | -8.59B | -3.44B |
| 2018 | 15.71B | -12.38B | -4.36B |
| 2019 | 18.46B | -12.69B | -5.62B |
| 2020 | 22.17B | -12.53B | -3.59B |
| 2021 | 22.34B | -10.37B | -7.45B |
| 2022 | 26.20B | -28.47B | 4.22B |
| 2023 | 29.06B | -15.57B | -11.52B |
UNH Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 23.36B | 21.37B | 16.92B | 10.98B | 10.86B | 11.98B | 10.43B | 10.92B | 7.49B | 7.27B |
Operating activities | ||||||||||
Net income | 22.38B | 20.63B | 17.73B | 15.76B | 14.23B | 12.38B | 10.82B | 7.29B | 5.86B | 5.61B |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 3.97B | 3.4B | 3.10B | 2.89B | 2.72B | 2.42B | 2.24B | 2.05B | 1.69B | 1.47B |
Stock-based compensation expense | 1.05B | 925M | 800M | 679M | 697M | 638M | 597M | 485M | 406M | 364M |
| Deferred income tax benefit | 1.05B | 925M | 800M | 679M | 697M | 638M | 597M | 485M | 406M | 364M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -3.11B | -2.52B | -1B | -688M | 162M | -1.35B | -1.06B | -1.35B | -591M | -911M |
Inventories | 1.03B | 0 | -1.03B | -2.19B | -1.56B | -750M | -630M | -1.82B | -793M | -595M |
Accounts payable | 3.51B | 1.96B | 3.86B | 5.5B | 1.95B | 2.35B | 2.21B | 3.34B | 3.22B | 2.12B |
Cash generated by operating activities | 29.06B | 26.20B | 22.34B | 22.17B | 18.46B | 15.71B | 13.59B | 9.79B | 9.74B | 8.05B |
Investing activities | ||||||||||
Purchases Of Investments | -18.31B | -6.83B | -1.84B | -2.83B | -2.50B | -4.09B | -4.31B | -5.92B | -531M | -9.92B |
Investments In Property Plant And Equipment | -3.38B | -2.80B | -2.45B | -2.05B | -2.07B | -2.06B | -2.02B | -1.70B | -1.55B | -1.44B |
Acquisitions Net | -10.13B | -21.45B | -4.82B | -7.13B | -8.34B | -5.99B | -2.13B | -1.76B | -16.16B | -1.92B |
Cash generated by investing activities | -15.57B | -28.47B | -10.37B | -12.53B | -12.69B | -12.38B | -8.59B | -9.35B | -18.39B | -2.53B |
Financing activities | ||||||||||
Common Stock Issued | 1.35B | 1.25B | 1.35B | 1.44B | 1.03B | 838M | 688M | 429M | 402M | 462M |
Payments for dividends | -6.76B | -5.99B | -5.28B | -4.58B | -3.93B | -3.32B | -2.77B | -2.26B | -1.78B | -1.36B |
Repurchases of common stock | -8B | -7B | -5B | -4.25B | -5.5B | -4.5B | -1.5B | -1.28B | -1.2B | -4.00B |
Repayments of term debt | 4.28B | 12.53B | -3.15B | -3.15B | 3.69B | -2.80B | -2.61B | -2.97B | 14.60B | -1.60B |
Cash used in financing activities | -11.52B | 4.22B | -7.45B | -3.59B | -5.62B | -4.36B | -3.44B | -1.01B | 12.23B | -5.29B |
Net Change In Cash | 2.06B | 1.99B | 4.45B | 5.93B | 119M | -1.11B | 1.55B | -493M | 3.42B | 219M |
Cash at end of period | 25.42B | 23.36B | 21.37B | 16.92B | 10.98B | 10.86B | 11.98B | 10.43B | 10.92B | 7.49B |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |